Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

ALPINE IMMUNE SCIENCES, INC. (NVLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Paradigm Biocapital Advisors LP has filed a Schedule 13D for ALPINE IMMUNE SCIENCES, INC.
02/14/2023 SC 13G/A GREAT POINT PARTNERS LLC reports a 7.9% stake in ALPINE IMMUNE SCIENCES, INC.
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 9.6% stake in ALPINE IMMUNE SCIENCES, INC.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 6.8% stake in Alpine Immune Sciences, Inc.
02/14/2023 SC 13G/A Avidity Partners Management LP reports a 4% stake in Alpine Immune Sciences, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Omega Fund VI, L.P. reports a 8.2% stake in Alpine Immune Sciences, Inc.
02/14/2022 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 5.4% stake in Alpine Immune Sciences, Inc.
02/11/2022 SC 13G/A Avidity Partners Management LP reports a 7.3% stake in Alpine Immune Sciences, Inc.
02/16/2021 SC 13G/A Avidity Partners Management LP reports a 6.2% stake in Alpine Immune Sciences, Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/27/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/10/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
03/22/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy